Video Shorts

Key Takeaways from Drug Topics’ APhA 2026 Coverage

Over the Counter Recap: The Hybrid Pharmacist

What Pharmacy Experts Loved About APhA 2026

The Key Pathway for GLP-1 Use in Treating Substance Use Disorder

How Language Shapes Harm Reduction

Current Evidence Regarding GLP-1s for Alcohol Use Disorder

Drug Topics' Weekly News Recap: April 6

Could GLP-1s Effectively Silence the Dopamine Spike in Addiction?

Over the Counter Recap: GLP-1s for Substance Use Disorder

The Best Way to Schedule Buprenorphine and Meals

Licensing and Buprenorphine Prescribing for Pharmacists

APhA Annual Meeting and Expo 2026

How MOMs Program Helped Patient Reach Her Third Trimester

Don't Use Research-Grade Ingredients In Compounding Pharmacy

Rediscovering the Four R’s of Trauma Care

How to Counsel Patients on Compounded GLP-1 Safety

Drug Topics' Weekly News Recap: March 23

The Truth About GLP-1 Compounding and FDA Rules

Over the Counter Recap: GLP-1 Compounding

Why Community Pharmacies Put People Before Prescriptions

The Future of Pharmacy: AI & Total Visibility

The National Scale of Test To Treat

The Hidden Economics of Why Generic Drugs Vanish

Drug Topics' Weekly News Recap: March 16

How Drug Shortages Impact Surgery and Pediatric Care

Over the Counter Recap: Addressing Drug Shortages

Are Compounded Peptides Just Hype or a Health Hazard?

Why an SOP is Your Best Defense in a Pharmacy Audit

mRNA Vaccines Do Not Rewrite DNA

National Women and Girls HIV/AIDS Awareness Day 2026